News
Sementis CEO Dr Anne Collins is recipient of DMTC’s Collaboration Award
February 2024 Sementis was delighted to be recognised at the 2024 DMTC Annual Conference, and our CEO Dr Anne Collins...
August 2021
Adelaide biotech company Sementis is aiming to raise $10m to accelerate work on its next-generation Covid-19 vaccine, which it hopes to have in production within 18 months.
Digital subscribers to The Australian can read more here.
News
February 2024 Sementis was delighted to be recognised at the 2024 DMTC Annual Conference, and our CEO Dr Anne Collins...
News
September 2023 Biotechnology company Sementis will advance its position at the forefront of vaccine technology with the...
News
January 2023 Sementis has exciting news. We’re pleased to announce that we’ve been awarded a $3 million Federal...